Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Armata Pharmaceuticals' AP-PA02, a therapeutic phage cocktail, is currently in Phase II trials for bronchiectasis and pseudomonal infections, targeting *P. aeruginosa* in respiratory infections.
BioMx completed patient enrollment for its Phase 2 trial of BX201 for Diabetic Foot Osteomyelitis (DFO), with topline results expected in Q1 2025.
BiomX's BX004 phage cocktail demonstrated favorable safety and notable efficacy in cystic fibrosis patients with chronic _Pseudomonas aeruginosa_ pulmonary infections.